“The best thing you can do with DNAnexus is give them a problem to solve.”
Pharma
Better targets, faster trials, cleaner submissions.
Trial data, real-world cohorts and public biobanks on one governed platform, so the findings emerge while they can still change the trial.
One platform. Cohort to Candidate.
DNAnexus puts your trial data, real-world cohorts and public biobanks in one governed workspace, modeled, versioned and queryable from day one.
A modern translational environment should work for people and agents alike.
It should let you take real-world cohorts, years of longitudinal claims and clinical records joined to omics, and interrogate them in plain language: test feasibility, derive endpoints straight from the record instead of recoding by hand, and run time-to-event and logistic models on clinical predictors where the data already lives.
It should let you qualify candidates against Open Targets, GTEx, UK Biobank and TCGA, mounted beside your own data, before anyone commits a wet lab.
AI programs in pharma stall on the data side, not the model side.
A modern data layer should take the disparate data you already have. Public and licensed references such as TCGA, GTEx and Open Targets should be mounted beside your data, so no model starts from a blank screen, and every feature matrix, response definition and result should carry its provenance.
That is what DNAnexus does for your translational and AI teams.
Bioinformatics and data science teams spend most of their time wrangling data rather than doing science. Give them back the week.
The access controls your governance team already enforces should not be the reason data stays locked up.
On DNAnexus, a central team can open data to the whole company safely: permissions and sub-environments are tiered by access level, so consent that differs from trial to trial or therapeutic area to therapeutic area is honored without building a separate environment for each.
When a biomarker is ready to become a companion diagnostic, the handoff happens on the same platform the leading diagnostics labs already run on.
Trusted Research Environments on DNAnexus give every collaborator a governed place to work inside your boundary.
An environment is stood up in days, in the region your data must stay in, with no egress; an acquired company can be working on your data within the same window.
Licensed real-world datasets arrive ingested, modeled and queryable from day one, and each quarterly clinical or sequencing refresh lands in the same model without re-ingestion.
This is the same technology behind the UK Biobank Research Analysis Platform and the UK Biobank Pharma Proteomics Project, where thirteen biopharma companies work on one dataset.
Consortium scale is where it started.
On DNAnexus the audit trail is a by-product of doing the work. Every job carries immutable QC and provenance from the first query, so the project workspace is the reproducibility package.
Analysis plans stay alive: the common data model specification and the SAP sit in shared notebooks linked to the code that implements them, so plan and execution stay verifiably in sync.
GxP and 21 CFR Part 11 readiness, HIPAA, GDPR and FedRAMP Moderate come as standard, and validated environments with turnkey computer system validation documentation cut the IQ/OQ effort you would otherwise carry yourself.
Secure Collaboration
- Data Access Management and Government
- Secure Internal and External Data Sharing
- Trusted Ressearch Environment
Multimodal Data Analysis
- AI/ML Algorithms
- Cohort Analysis
- Data Visualization
Multimodal Data Management
- Metadata capture
- Data catalog
- RWD enrichment
“Security is super important to us and the DNAnexus platform has an absolutely fantastic security model underneath.”
"DNAnexus has made it easy for us to remove the costs and technical headaches associated with building a do-it-yourself alternative."
Fresh Perspectives
-
15 September 2026
Setting Yourself Up For Success: Choosing The Right Omics Platform For Your Diagnostics Pipeline
Planning for the growth and maturation of a diagnostic pipeline can be daunting. DNAnexus offers four packages to help enable diagnostic test providers during whatever stage they are in.
Clinical Diagnostics
-
23 July 2026
The Bioinformatician’s Fever Dream: Data Nirvana or Just a Really Stable Manifest?
Explore the future of bioinformatics with harmonized, AI-ready data that transforms clinical workflows, enhances precision medicine, and drives drug discovery.
-
30 June 2026
Building a Measurable Evidence Engine for Cell, Gene, and RNA Therapies
Discover how integrating multi-omic data can uncover insights into patient responses to therapies, driving advancements in cell, gene, and RNA research.